Oliver Werz
- Pharmacology top 0.05%
- Inflammatory mediators and NSAID effects 120
- Pharmacological Effects of Medicinal Plants 32
- Toxicology top 0.05%
- Bioactive Compounds and Antitumor Agents 38
- Biochemistry top 0.1%
- Eicosanoids and Hypertension Pharmacology 45
- Organic Chemistry top 0.5%
- Synthesis and biological activity 40
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology 45
-
- Estrogen and related hormone effects 54
-
- Asthma and respiratory diseases 49
-
- Immune Response and Inflammation 39
- Co-authors
- Dieter SteinhilberAndreas KoeberleOlof RådmarkBengt SamuelssonCarlo PergolaHinnak NorthoffManfred Schubert‐ZsilaveczLidia Sautebin
- Cited by
- PharmacologyToxicologyBiochemistry
In The Last Decade
Oliver Werz
436 papers receiving 14.7k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Pharmacology 5.1k
- Toxicology 835
- Biochemistry 1.5k
- Organic Chemistry 2.9k
- Biochemistry 585
Countries citing papers authored by Oliver Werz
This map shows the geographic impact of Oliver Werz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Werz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Werz more than expected).
Fields of papers citing papers by Oliver Werz
This network shows the impact of papers produced by Oliver Werz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Werz. The network helps show where Oliver Werz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Oliver Werz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 5 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 14 | |
| 12 | 2023 | 34 | |
| 13 | 2023 | 5 | |
| 14 | Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201 | 2022 | 18 |
| 15 | 2021 | 18 | |
| 16 | 2021 | 20 | |
| 17 | 2020 | 59 | |
| 18 | 2020 | 165 | |
| 19 | 2020 | 5 | |
| 20 | 2013 | 1 |
About Oliver Werz
Oliver Werz is a scholar working on Toxicology, Pharmacology and Biochemistry, having authored 450 papers that have together received 15.0k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (120 papers), Estrogen and related hormone effects (54 papers), Asthma and respiratory diseases (49 papers), Eicosanoids and Hypertension Pharmacology (45 papers), Synthesis and biological activity (40 papers), Immune Response and Inflammation (39 papers), Bioactive Compounds and Antitumor Agents (38 papers) and Pharmacological Effects of Medicinal Plants (32 papers). The work is most often cited by research in Pharmacology (5.1k citations), Toxicology (835 citations) and Biochemistry (1.5k citations). Oliver Werz has collaborated with scholars based in Germany, Italy and Austria. Frequent co-authors include Dieter Steinhilber, Andreas Koeberle, Olof Rådmark, Bengt Samuelsson, Carlo Pergola, Hinnak Northoff, Manfred Schubert‐Zsilavecz, Lidia Sautebin, Jana Gerstmeier and Antonietta Rossi. Their work appears in journals such as European Journal of Medicinal Chemistry, Biochemical Pharmacology, Journal of Medicinal Chemistry, The FASEB Journal and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.